The Division of Pharmacy at the University of Texas MD Anderson Cancer Center offers a PGY2 Pharmacy Residency in Medication-Use Safety and Policy. MD Anderson is a world renowned 650+ bed acute patient care and 5100+ visit/day outpatient cancer center located in the Texas Medical Center.
The residency program provides a broad range of medication use management experiences with an emphasis in drug information including formulary management and implementation, drug shortage management, policy and accreditation, fostering a culture of safety, evaluating and reporting adverse drug reactions and medication errors, and quality improvement. Residents are provided opportunities to develop skills in critical literature evaluation, evidence-based medicine, interdisciplinary committee coordination, and clinical informatics. The program allows for tailored instruction for the individual resident based on interest(s), past experience, and future goals. The PGY2 Pharmacy Residency in Medication-Use Safety and Policy will develop practitioners capable of serving as an expert on drug information and optimal medication use in a hospital/health-system setting. Following completion of the residency, graduates will be prepared for a position in drug information, formulary management, drug shortage management, drug-use policy, medication safety, policy and accreditation, drug utilization, or related role within health system pharmacy.
MD Anderson Cancer Center is an Equal Opportunity Employer
The start date for this residency program is mid-July
The annual stipend for this program is $60,000
PGY2 Medication-Use Safety and Policy resident positions = 1
PharmD degree from an accredited school of pharmacy
Completion of an ASHP-accredited PGY1 Pharmacy Practice residency program
Eligible for licensure in the state of Texas
Completion of PhORCAS application
On-site interview required
Additional Salary Information: Employee free medical insurance - Vacation, sick leave, and conference time - No state income tax
About MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. It is located in central Houston in the Texas Medical Center. U.S. News & World Report’s "Best Hospitals" survey has ranked MD Anderson as one of the nation’s top two cancer centers every year since the survey began in 1990. The institution has over 650 inpatient beds and sees over 1.3 million outpatient visits per year. The Division of Pharmacy has over 600 employee's including over 250 registered pharmacists.